Insight Molecular Diagnostics (IMDX) Return on Invested Capital (2020 - 2024)

Insight Molecular Diagnostics has disclosed Return on Invested Capital across 3 years of filings, most recently posting 0.03% for Q3 2024.

• Return on Invested Capital for Q3 2024 came in at 0.03%, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was 0.03% (changed N/A YoY), and the FY2022 annual result was 0.0%, up 1.0% from the prior year.
• Return on Invested Capital came in at 0.03% for Q3 2024 at Insight Molecular Diagnostics, down from 0.02% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q2 2021 to a low of 0.03% in Q3 2024.
• The 3-year median for Return on Invested Capital is 0.01% (2020), against an average of 0.01%.
• Peak annual rise in Return on Invested Capital reached 0 bps in 2021, while the deepest fall reached 0 bps in 2021.
• Insight Molecular Diagnostics' Return on Invested Capital stood at 0.01% in 2020, then advanced by 3 bps to 0.01% in 2021, then plunged by 232 bps to 0.03% in 2024.
• The last three Return on Invested Capital figures came in at 0.03% (Q3 2024), 0.02% (Q2 2024), and 0.02% (Q1 2024), per Business Quant data.